Panacea Biotec Limited

NSEI:PANACEABIO 주식 보고서

시가총액: ₹25.1b

Panacea Biotec 관리

관리 기준 확인 3/4

Panacea Biotec CEO는 Rajesh Jain, Feb2002 에 임명되었습니다 의 임기는 22.75 년입니다. 총 연간 보상은 ₹ 9.01M, 66.6% 로 구성됩니다. 66.6% 급여 및 33.4% 보너스(회사 주식 및 옵션 포함). 는 ₹ 12.39B 가치에 해당하는 회사 주식의 49.33% 직접 소유합니다. 12.39B. 경영진과 이사회의 평균 재임 기간은 각각 9.5 년과 8.6 년입니다.

주요 정보

Rajesh Jain

최고 경영자

₹9.0m

총 보상

CEO 급여 비율66.6%
CEO 임기22.8yrs
CEO 소유권49.3%
경영진 평균 재임 기간9.5yrs
이사회 평균 재임 기간8.6yrs

최근 관리 업데이트

Most Shareholders Will Probably Find That The Compensation For Panacea Biotec Limited's (NSE:PANACEABIO) CEO Is Reasonable

Sep 21
Most Shareholders Will Probably Find That The Compensation For Panacea Biotec Limited's (NSE:PANACEABIO) CEO Is Reasonable

Recent updates

There's No Escaping Panacea Biotec Limited's (NSE:PANACEABIO) Muted Revenues Despite A 34% Share Price Rise

Nov 22
There's No Escaping Panacea Biotec Limited's (NSE:PANACEABIO) Muted Revenues Despite A 34% Share Price Rise

There's No Escaping Panacea Biotec Limited's (NSE:PANACEABIO) Muted Revenues Despite A 40% Share Price Rise

Oct 03
There's No Escaping Panacea Biotec Limited's (NSE:PANACEABIO) Muted Revenues Despite A 40% Share Price Rise

Most Shareholders Will Probably Find That The Compensation For Panacea Biotec Limited's (NSE:PANACEABIO) CEO Is Reasonable

Sep 21
Most Shareholders Will Probably Find That The Compensation For Panacea Biotec Limited's (NSE:PANACEABIO) CEO Is Reasonable

Panacea Biotec Limited (NSE:PANACEABIO) Held Back By Insufficient Growth Even After Shares Climb 25%

Aug 19
Panacea Biotec Limited (NSE:PANACEABIO) Held Back By Insufficient Growth Even After Shares Climb 25%

Does Panacea Biotec (NSE:PANACEABIO) Have A Healthy Balance Sheet?

Jun 05
Does Panacea Biotec (NSE:PANACEABIO) Have A Healthy Balance Sheet?

Why Investors Shouldn't Be Surprised By Panacea Biotec Limited's (NSE:PANACEABIO) Low P/S

Apr 04
Why Investors Shouldn't Be Surprised By Panacea Biotec Limited's (NSE:PANACEABIO) Low P/S

Why We Think Panacea Biotec Limited's (NSE:PANACEABIO) CEO Compensation Is Not Excessive At All

Sep 23
Why We Think Panacea Biotec Limited's (NSE:PANACEABIO) CEO Compensation Is Not Excessive At All

Estimating The Fair Value Of Panacea Biotec Limited (NSE:PANACEABIO)

Jul 28
Estimating The Fair Value Of Panacea Biotec Limited (NSE:PANACEABIO)

How Does Panacea Biotec's (NSE:PANACEABIO) CEO Pay Compare With Company Performance?

Feb 14
How Does Panacea Biotec's (NSE:PANACEABIO) CEO Pay Compare With Company Performance?

Introducing Panacea Biotec (NSE:PANACEABIO), A Stock That Climbed 80% In The Last Five Years

Jan 06
Introducing Panacea Biotec (NSE:PANACEABIO), A Stock That Climbed 80% In The Last Five Years

Is Panacea Biotec (NSE:PANACEABIO) Using Too Much Debt?

Sep 17
Is Panacea Biotec (NSE:PANACEABIO) Using Too Much Debt?

If You Had Bought Panacea Biotec (NSE:PANACEABIO) Stock A Year Ago, You Could Pocket A 78% Gain Today

Aug 03
If You Had Bought Panacea Biotec (NSE:PANACEABIO) Stock A Year Ago, You Could Pocket A 78% Gain Today

CEO 보상 분석

Rajesh Jain 의 보수는 Panacea Biotec 의 수익과 비교하여 어떻게 변경되었나요?
날짜총 보상급여회사 수익
Sep 30 2024n/an/a

-₹147m

Jun 30 2024n/an/a

-₹279m

Mar 31 2024₹9m₹6m

-₹12m

Dec 31 2023n/an/a

-₹117m

Sep 30 2023n/an/a

₹99m

Jun 30 2023n/an/a

₹334m

Mar 31 2023₹8m₹6m

-₹332m

Dec 31 2022n/an/a

₹12b

Sep 30 2022n/an/a

₹11b

Jun 30 2022n/an/a

₹11b

Mar 31 2022₹8m₹6m

₹11b

Dec 31 2021n/an/a

-₹2b

Sep 30 2021n/an/a

-₹2b

Jun 30 2021n/an/a

-₹2b

Mar 31 2021₹7m₹6m

-₹1b

Dec 31 2020n/an/a

-₹2b

Sep 30 2020n/an/a

-₹1b

Jun 30 2020n/an/a

-₹2b

Mar 31 2020₹8m₹6m

-₹2b

Dec 31 2019n/an/a

₹653m

Sep 30 2019n/an/a

₹715m

Jun 30 2019n/an/a

₹482m

Mar 31 2019₹7m₹6m

₹410m

Mar 31 2018₹7m₹6m

-₹716m

보상 대 시장: Rajesh 의 총 보상 ($USD 106.89K ) Indian 시장에서 비슷한 규모의 회사에 대한 평균보다 낮습니다( $USD 194.11K ).

보상과 수익: 회사가 수익성이 없는 동안 Rajesh 의 보상이 증가했습니다.

CEO

Rajesh Jain (60 yo)

22.8yrs

테뉴어

₹9,010,000

보상

Dr. Rajesh Jain, Ph D has been Managing Director at Panacea Biotec Limited since March 12, 2018 and serves as its Whole-Time Director and serves as its Chairman of the Board at Panacea Biotec Limited since...

리더십 팀

이름위치테뉴어보상소유권
Rajesh Jain
Chairman of the Board & MD22.8yrs₹9.01m49.33%
₹ 12.4b
Sandeep Jain
Joint MD & Executive Director22.8yrs₹8.37m15.45%
₹ 3.9b
Devender Gupta
CFO & Head of Information Technology9.5yrs₹6.43m데이터 없음
Khalid Syed
Chief Scientific Officerno data₹6.53m데이터 없음
Vinod Goel
Group CFO9.5yrs₹8.43m데이터 없음
Ankesh Jain
Whole-Time Directorless than a year₹3.03m데이터 없음
Rajeeva Mangalum
Chief Operating Officer5yrs데이터 없음데이터 없음
Naresh Gupta
General Manager of Accounts & Taxationno data데이터 없음데이터 없음
Ashish Jain
Chief Information Officerno data데이터 없음0.00082%
₹ 205.9k
Gurinder Singh
Senior Vice President of Salesno data₹5.61m데이터 없음
Kulvinder Sarao
Senior Vice President of Human Resourcesno data₹6.10m데이터 없음
Dinesh Singla
Senior Vice President of Pharma Research & Pharma Regulatory Affairs5yrs데이터 없음데이터 없음

9.5yrs

평균 재임 기간

58yo

평균 연령

경험이 풍부한 관리: PANACEABIO 의 관리팀은 노련하고 경험 (평균 재직 기간 9.5 년)입니다.

이사회 구성원

이름위치테뉴어보상소유권
Rajesh Jain
Chairman of the Board & MD40yrs₹9.01m49.33%
₹ 12.4b
Sandeep Jain
Joint MD & Executive Director40yrs₹8.37m15.45%
₹ 3.9b
Ankesh Jain
Whole-Time Director8.6yrs₹3.03m데이터 없음
Narotam Juneja
Additional Non-Executive Non-Independent Director2.6yrs₹22.00k데이터 없음
Manjula Upadhyay
Non-Executive Independent Director9.7yrs₹20.00k데이터 없음
Mukul Gupta
Non-Executive Independent Director8.6yrs₹20.00k데이터 없음
Ambika Sharma
Non-Executive Independent Directorless than a year데이터 없음데이터 없음

8.6yrs

평균 재임 기간

63yo

평균 연령

경험이 풍부한 이사회: PANACEABIO 의 이사회는 경험(평균 재직 기간 8.6 년)으로 간주됩니다.